. Expands specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing Complements leading life sciences offering with innovative sample preparation, assay and bioinformatics technologies Creates significant value and is expected to be immediately accretive to adjusted earnings […]